Potential virtual lead identification in the discovery of renin inhibitors: Application of ligand and structure-based pharmacophore modeling approaches-Reference-Cited by-同舟云学术

Potential virtual lead identification in the discovery of renin inhibitors: Application of ligand and structure-based pharmacophore modeling approaches

Published:2011-06 Issue:6 Volume:46 Page:2469-2476
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Thangapandian Sundarapandian,John Shalini,Sakkiah Sugunadevi,Lee Keun Woo

Funder

Basic Science Research Program

Pioneer Research Center Program

Environmental Biotechnology National Core Research Center program

Ministry of Education, Science and Technology (MEST)

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference27 articles.

1. Molecular cloning of a novel mouse aspartic protease-like protein that is expressed abundantly in the kidney

2. Current concepts: renin inhibition in the treatment of hypertension

3. Oral renin inhibitors

4. Renin Inhibition in Hypertension

5. Antibodies to Renin as Proof of the Pathogenesis of Sustained Renal Hypertension

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of novel renin inhibitory peptides from tartary buckwheat albumin hydrolysates by molecular docking;Process Biochemistry;2024-03

2. Integration of ligand and structure-based pharmacophore screening for the identification of novel natural leads against Euchromatic histone lysine methyltransferase 2 (EHMT2/G9a);Journal of Biomolecular Structure and Dynamics;2023-05-22

3. Insight parameter drug design for human β-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of α-keto-[1,2,4]-oxadiazoles;Journal of Biomolecular Structure and Dynamics;2023-01-29

4. Designing Novel Compounds for the Treatment and Management of RET-Positive Non-Small Cell Lung Cancer—Fragment Based Drug Design Strategy;Molecules;2022-02-28

5. Chemical constituents, pharmacological activities, and uses of common ayurvedic medicinal plants: a future source of new drugs;Advances in Traditional Medicine;2021-11-23